Percentage of applications granted has been kept above 10% (by funding shorter projects and concentrating on funding staff costs). In 2017, the new system has increased the percentage funded to 16%.

Total publications citing ERAB as a source of funding is now 199 (average of 14 each year, over 2 per grant).

Operating budget split is being maintained at, or around, 90% dedicated to grants.

3. Visibility

At conferences, by grantees and travel award recipients presenting their results and citing ERAB as the source of funding.

At the International Meeting on Alcohol and Global Health (IMAG) conference, every four years. Next one 2018.

In the research community, measured by the growing number of research teams applying.

Stakeholders are kept up to date with developments by regular communication via the electronic Newsletter, the Annual report and occasional publications / presentations.

Links between the biomedical and brewing research communities are being developed by annual meetings with brewing scientists.

Links / collaboration with the European Commission / WHO etc. a longer term objective. Commission 2016 Workplan provided opportunities which ERAB was unable to exploit.

4. Impact

Impact assessment shows measurable impact of some earlier grants, for example ‘being quoted in Government guidelines’ etc. and ERAB “seed corn” funding helps grantees get additional support for their research.

Funding of younger scientists, measured by the number of PhDs etc awarded to members of ERAB grantees teams, and travel and exchange awards build a knowledgeable research community.

ERAB has been awarded “tax deductible status” for Belgium. This was renewed in 2017.